139 related articles for article (PubMed ID: 22547412)
21. Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI.
Geurts JJ; Roosendaal SD; Calabrese M; Ciccarelli O; Agosta F; Chard DT; Gass A; Huerga E; Moraal B; Pareto D; Rocca MA; Wattjes MP; Yousry TA; Uitdehaag BM; Barkhof F;
Neurology; 2011 Feb; 76(5):418-24. PubMed ID: 21209373
[TBL] [Abstract][Full Text] [Related]
22. Magnetic resonance imaging in multiple sclerosis.
Napoli SQ; Bakshi R
Rev Neurol Dis; 2005; 2(3):109-16. PubMed ID: 16400309
[TBL] [Abstract][Full Text] [Related]
23. Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis.
Gordon-Lipkin E; Chodkowski B; Reich DS; Smith SA; Pulicken M; Balcer LJ; Frohman EM; Cutter G; Calabresi PA
Neurology; 2007 Oct; 69(16):1603-9. PubMed ID: 17938370
[TBL] [Abstract][Full Text] [Related]
24. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
Sepulcre J; Goñi J; Masdeu JC; Bejarano B; Vélez de Mendizábal N; Toledo JB; Villoslada P
Arch Neurol; 2009 Feb; 66(2):173-9. PubMed ID: 19204153
[TBL] [Abstract][Full Text] [Related]
25. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N
Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589
[TBL] [Abstract][Full Text] [Related]
26. The role of magnetic resonance imaging in the study of multiple sclerosis: diagnosis, prognosis and understanding disease pathophysiology.
Filippi M; Rocca MA
Acta Neurol Belg; 2011 Jun; 111(2):89-98. PubMed ID: 21748926
[TBL] [Abstract][Full Text] [Related]
27. The relationship between whole brain volume and disability in multiple sclerosis: a comparison of normalized gray vs. white matter with misclassification correction.
Sanfilipo MP; Benedict RH; Sharma J; Weinstock-Guttman B; Bakshi R
Neuroimage; 2005 Jul; 26(4):1068-77. PubMed ID: 15961046
[TBL] [Abstract][Full Text] [Related]
28. May there exist specific MRI findings predictive of dementia in multiple sclerosis patients?
Patti F; Di Stefano M; De Pascalis D; Ciancio MR; De Bernardis E; Nicoletti F; Reggio A
Funct Neurol; 1995; 10(2):83-90. PubMed ID: 7557556
[TBL] [Abstract][Full Text] [Related]
29. A preliminary study of magnetization transfer and diffusion tensor MRI of multiple sclerosis patients with fatigue.
Codella M; Rocca MA; Colombo B; Rossi P; Comi G; Filippi M
J Neurol; 2002 May; 249(5):535-7. PubMed ID: 12021941
[TBL] [Abstract][Full Text] [Related]
30. Baseline MRI predicts future attacks and disability in clinically isolated syndromes.
Tintoré M; Rovira A; Río J; Nos C; Grivé E; Téllez N; Pelayo R; Comabella M; Sastre-Garriga J; Montalban X
Neurology; 2006 Sep; 67(6):968-72. PubMed ID: 17000962
[TBL] [Abstract][Full Text] [Related]
31. Association between MRI parameters and the MS severity scale: a 12 year follow-up study.
Minneboo A; Uitdehaag BM; Jongen P; Vrenken H; Knol Dl; van Walderveen MA; Polman CH; Castelijns JA; Barkhof F
Mult Scler; 2009 May; 15(5):632-7. PubMed ID: 19389751
[TBL] [Abstract][Full Text] [Related]
32. [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis].
Zivadinov R; Sepcić J
Lijec Vjesn; 2006; 128(9-10):295-308. PubMed ID: 17128669
[TBL] [Abstract][Full Text] [Related]
33. Intrathecal immunoglobulin G synthesis and brain injury by quantitative MRI in multiple sclerosis.
Brandão CO; Ruocco HH; Farias AS; Oliveira C; Cendes F; Damasceno BP; Santos LM
Neuroimmunomodulation; 2006; 13(2):89-95. PubMed ID: 17033198
[TBL] [Abstract][Full Text] [Related]
34. Clinical-magnetic resonance imaging correlations in multiple sclerosis.
Zivadinov R; Leist TP
J Neuroimaging; 2005; 15(4 Suppl):10S-21S. PubMed ID: 16385015
[TBL] [Abstract][Full Text] [Related]
35. Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS.
Portaccio E; Zipoli V; Goretti B; De Stefano N; Amato MP
J Neurol Sci; 2009 Sep; 284(1-2):223; author reply 223-4. PubMed ID: 19428029
[No Abstract] [Full Text] [Related]
36. [Course of illness and prognosis of multiple sclerosis. 2: Predictive value of clinical and paraclinical factors].
Flachenecker P; Hartung HP
Nervenarzt; 1996 Jun; 67(6):444-51. PubMed ID: 8767198
[TBL] [Abstract][Full Text] [Related]
37. Motor evoked potential: a reliable and objective measure to document the functional consequences of multiple sclerosis? Relation to disability and MRI.
Kalkers NF; Strijers RL; Jasperse MM; Neacsu V; Geurts JJ; Barkhof F; Polman CH; Stam CJ
Clin Neurophysiol; 2007 Jun; 118(6):1332-40. PubMed ID: 17398151
[TBL] [Abstract][Full Text] [Related]
38. Multiparametric MR investigation of the motor pyramidal system in patients with 'truly benign' multiple sclerosis.
Spanò B; Cercignani M; Basile B; Romano S; Mannu R; Centonze D; Caltagirone C; Bramanti P; Nocentini U; Bozzali M
Mult Scler; 2010 Feb; 16(2):178-88. PubMed ID: 20007429
[TBL] [Abstract][Full Text] [Related]
39. Thalamic atrophy and cognition in multiple sclerosis.
Houtchens MK; Benedict RH; Killiany R; Sharma J; Jaisani Z; Singh B; Weinstock-Guttman B; Guttmann CR; Bakshi R
Neurology; 2007 Sep; 69(12):1213-23. PubMed ID: 17875909
[TBL] [Abstract][Full Text] [Related]
40. Integrating the tools for an individualized prognosis in multiple sclerosis.
Fernández O
J Neurol Sci; 2013 Aug; 331(1-2):10-3. PubMed ID: 23692966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
